Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>WINT</strong> +16.9%, <strong>TIVO</strong> +13.6%, <strong>CSLT</strong> +12.7%, <strong>SNPS</strong> +7.6%, <strong>NTES</strong> +7.3%, <strong>KATE</strong> +6.8%, (also announce it is reviewing strategic alternatives) <strong>NTAP</strong> +5.3%</li><li><strong>QUIK</strong> +4.2%, <strong>CRY</strong> +4.1%, <strong>SRCL</strong> +4%, <strong>NGD</strong> +3.9%, <strong>TPX</strong> +3.9%, <strong>ALXN</strong> +3.4%, <strong>LBTYA</strong> +3.3%, <strong>CIR</strong> +3.3%, <strong>GNCA</strong> +2.4%, <strong>NMIH</strong> +2.1%, <strong>GG</strong> +2%, <strong>ABX</strong> +2%</li><li><strong>CHH</strong> +1.7%, <strong>CSCO</strong> +1.6%, <strong>SHPG</strong> +1.6%, <strong>EQIX</strong> +1.4%, <strong>AMAT</strong> +1.4%, <strong>SSNC</strong> +1.3%, <strong>PBFX</strong> +1.2%, <strong>GFI</strong> +1.2%, <strong>CVA</strong> +1%, <strong>TRP</strong> +1%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>HGG</strong> +17.5% (HHGregg confirms plans to explore strategic alternatives)</li><li><strong>RAD</strong> +2.6% (Walgreens (WBA) is optimistic regarding FTC approval for RAD M&A deal due to divesture package, according to NY Post)</li><li><strong>BIDU</strong> +0.5% (acquired digital assistant startup Raven Tech, according to TechCrunch)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>XTLB</strong> +58.4% (continued strength), <strong>SCON</strong> +42.6% (receives a U.S. Patent enabled by STI's proprietary superconducting wire manufacturing method)</li><li><strong>MDGS</strong> +37.4% (announces tha tthe China FDA has approved the commencement of the first multi-center MUSE Clinical Study in China)</li><li><strong>CVRS</strong> +22.7% (Corindus Vascular Robotics announces a distribution agreement w/ a subsidiary of Mitsubishi (MSBHY); includes an initial order for 12 CorPath GRX Systems accompanied by an advance of $2 million toward the purchase price), <strong>RUBI</strong> +11% (still checking), <strong>BLDP</strong> +7.6% (receives 5-year, $25 mln deal Broad-Ocean Motor Co)</li><li><strong>PGNX</strong> +5.6% (to join S&P SmallCap 600), <strong>SFLY</strong> +3.1% (to join S&P SmallCap 600)</li><li><strong>VRX</strong> +2.6% (FDA approves Siliq to treat adults with moderate-to-severe plaque psoriasis)</li><li><strong>TTM</strong> +2.3% (Tata Motors and and Microsoft (MSFT) India confirm that cos will collaborate on connected cars)</li><li><strong>FOLD</strong> +2.1% (presents additional positive preliminary Phase 1/2 Data; demonstrates improving trends in majority of patients)</li><li><strong>FL</strong> +1.3% (increases quarterly dividend to $0.31/share from $0.28/share; approves a new 3-year $1.2 bln share repurchase program extending through January 2020, replacing the previous $1 bln program; approves $277 mln capital expenditure program for 2017)</li><li><strong>GSK</strong> +1% (in sympathy with SHPG earnings)</li><li><strong>ALGN</strong> +0.9% (announces it has prevailed in proceedings initiated by ClearCorrect Operating that challenged the validity of three of its U.S. patents)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>MDCA</strong> +4.6% (upgraded to Buy from Hold at Jefferies)</li></ul></td> </tr></table>"